Biopol Chemicals IPO
IPO Listing Details
- Listing Date
13 Feb 2026
- Listing Price
₹ 111.00
- Listing Change
-
- Last Traded Price
₹ 105.50
Biopol Chemicals IPO Details
-
Open Date
06 Feb 2026
-
Close Date
10 Feb 2026
-
Listing Date
13 Feb 2026
- IPO Price Range
₹ 102 to ₹108
- IPO Size
₹ 31.26 Cr
- Listing Exchange
NSE SME
Biopol Chemicals IPO Timeline
Biopol Chemicals IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 06-Feb-2026 | 0.00 | 0.16 | 0.19 | 0.13 |
| 09-Feb-2026 | 4.00 | 0.79 | 1.01 | 1.67 |
| 10-Feb-2026 | 21.05 | 24.49 | 20.80 | 22.33 |
Last Updated: 10 February 2026 6:56 PM by 5paisa
Biopol Chemicals Limited manufactures and distributes specialty chemicals across silicones, emulsifiers, biochemicals and polyelectrolytes. Its portfolio comprises 66 products serving industries such as textiles, home care, agriculture and industrial chemicals. Operating on a B2B model, the company serves institutional clients. It has four establishments in Gujarat and West Bengal, with a manufacturing facility in West Bengal having an installed capacity of 18,25,000 litres per annum.
Established in: 2023
Managing Director: Mr. Santanu Sarkar
Peers:
Rossari Biotech Limited
Fineotex Chemical Limited
Indian Emulsifiers Limited
Biopol Chemicals Objectives
1. The Company will acquire industrial land amounting to ₹12.26 crore.
2. Funds will be used to repay borrowings of ₹11.10 crore.
3. Proceeds will support general corporate purposes.
Biopol Chemicals IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹31.26 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹31.26 Cr |
Biopol Chemicals IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | 2,44,800 |
| Retail (Max) | 2 | 2,400 | 2,59,200 |
| S-HNI (Min) | 3 | 3,600 | 3,67,200 |
| S-HNI (Max) | 7 | 8,400 | 9,07,200 |
| B-HNI (Min) | 8 | 9,600 | 9,79,200 |
Biopol Chemicals IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 21.05 | 6,86,400 | 1,44,49,200 | 156.051 |
| Non-Institutional Buyers | 24.49 | 10,94,400 | 2,67,97,200 | 289.410 |
| BNII | 27.49 | 7,29,600 | 2,00,54,400 | 216.588 |
| SNII | 18.48 | 3,64,800 | 67,42,800 | 72.822 |
| Individual Investors (IND category bidding for 2 Lots) | 20.80 | 9,62,400 | 2,00,18,400 | 216.199 |
| Total** | 22.33 | 27,43,200 | 6,12,64,800 | 661.660 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | 19.32 | 25.47 | 49.13 |
| EBITDA | 1.56 | 4.43 | 6.53 |
| PAT | 0.53 | 2.96 | 4.33 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 12.43 | 17.56 | 31.48 |
| Share Capital | 0.00 | 7.91 | 7.91 |
| Total Liabilities | 12.43 | 17.56 | 31.48 |
| Cash Flows (₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | 0.24 | -8.87 | -2.34 |
| Net Cash Generated From / (used in) Investing Activities | -0.49 | -0.07 | -0.02 |
| Net Cash Generated From / (used in) Financing Activities | 0.14 | 9.02 | 3.43 |
| Net Increase (Decrease) in Cash and Cash Equivalents | -0.12 | 0.08 | 1.07 |
Strengths
1. Diverse specialty chemical product portfolio
2. Strong presence in silicone-based chemicals
3. B2B model with institutional clientele
4. Multi-industry application across key sectors
Weaknesses
1. Limited geographic manufacturing footprint
2. Dependence on industrial client demand cycles
3. Moderate installed production capacity constraints
4. Product concentration in specialty chemical segments
Opportunities
1. Growing demand for specialty chemicals globally
2. Expansion into new industrial application areas
3. Capacity expansion to support future growth
4. Increasing adoption of sustainable chemical solutions
Threats
1. Volatility in raw material prices
2. Intense competition from larger chemical players
3. Regulatory changes impacting chemical manufacturing
4. Economic slowdowns affecting industrial demand
1. Diversified specialty chemical product portfolio
2. Presence across multiple end-use industries
3. Focus on capacity expansion and growth
4. B2B business model with repeat clients
Biopol Chemicals operates in the specialty chemicals segment, catering to diverse industries such as textiles, home care, agriculture and industrial applications. With a broad product portfolio and B2B-focused operations, the company is well positioned to benefit from rising demand for customised chemical solutions. Planned capacity expansion and strategic investments are expected to support long-term growth and operational scalability.
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Biopol Chemicals IPO opens from February 6, 2026 to February 10, 2026.
The size of Biopol Chemicals IPO is ₹31.26 Cr.
The price band of Biopol Chemicals IPO is fixed at ₹102 to ₹108 per share.
To apply for Biopol Chemicals IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Biopol Chemicals. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Biopol Chemicals IPO is of 2,400 shares and the investment required is ₹2,44,800.
The share allotment date of Biopol Chemicals IPO is February 9,2026
The Biopol Chemicals IPO will likely be listed on February 13, 2026.
Smart Horizon Capital Advisors Pvt.Ltd is the book running lead managers for Biopol Chemicals IPO.
Biopol Chemicals IPO plans to utilise the raised capital from the IPO for:
1. The Company will acquire industrial land amounting to ₹12.26 crore.
2. Funds will be used to repay borrowings of ₹11.10 crore.
3. Proceeds will support general corporate purposes.